Importance of spliceosomal RNP1 motif for intermolecular T-B cell spreading and tolerance restoration in lupus

Arthritis Research and Therapy

Volumn 9, Issue 5, 2007, Pages

  Monneaux, Fanny ^a   Parietti, Véronique ^a   Briand, Jean Paul ^a   Muller, Sylviane ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGIC AGENT; PEPTIDE DERIVATIVE; PROTEIN ANTIBODY; PROTEIN P140; PROTEIN RNP A2; PROTEIN RNP1; PROTEIN SMD1; PROTEIN U1 70K; PROTEIN U1 A; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; RNP1 PROTEIN, S CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CELL SPREADING; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PROTEIN DETERMINATION; PROTEIN INTERACTION; PROTEIN MOTIF; SPLICEOSOME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; AMINO ACID SEQUENCE; ANIMAL; B LYMPHOCYTE; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PHYSIOLOGY; T LYMPHOCYTE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; B-LYMPHOCYTES; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED MRL LPR; MOLECULAR SEQUENCE DATA; RNA-BINDING PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; SPLICEOSOMES; T-LYMPHOCYTES;

EID: 36849014916     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2317     Document Type: Article

References (38)

1. James JA Harley JB: B-cell epitope spreading in autoimmunity. Immunol Rev 1998, 164:185-200. 10.1111/j.1600-065X.1998.tb01220.x 9795776
2. Hirata D Iwamoto M Yoshio T Okazaki H Masuyama J Mimori A Minota S: Nucleolin as the earliest target molecule of autoantibodies produced in MRL/lpr lupus-prone mice. Clin Immunol 2000, 97:50-58. 10.1006/ clim.2000.4916 10998317
3. Dumortier H Monneaux F Jahn-Schmid B Briand JP Skriner K Cohen PL Smolen JS Steiner G Muller S: B and T cell responses to the spliceosomal heterogeneous nuclear ribonucleoproteins A2 and B1 in normal and lupus mice. J Immunol 2000, 165:2297-2305. 10925319
4. Arbuckle MR McClain MT Rubertone MV Scofield RH Dennis GJ James JA Harley JB: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 349:1526-1533. 10.1056/ NEJMoa021933 14561795
5. Lehmann PV Forsthuber T Miller A Sercarz EE: Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992, 358:155-157. 10.1038/358155a0 1377368
6. Dai YD Carayanniotis G Sercarz E: Antigen processing by autoreactive B cells promotes determinant spreading. Cell Mol Immunol 2005, 2:169-175. 16212883
7. Tian J Zekzer D Lu Y Dang H Kaufman DL: B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice. J Immunol 2006, 176:2654-2661. 16456028
8. Monneaux F Briand JP Muller S: B and T cell immune response to small nuclear ribonucleoprotein particles in lupus mice: Autoreactive CD4(+) T cells recognize a T cell epitope located within the RNP80 motif of the 70 K protein. Eur J Immunol 2000, 30:2191-2200. 10.1002/ 1521-4141(2000)30:8<2191::AID-IMMU2191>3.0.CO;2-R 10940910
9. Monneaux F Lozano JM Patarroyo ME Briand JP Muller S: T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70 K snRNP protein administered in MR/lpr mice. Eur J Immunol 2003, 33:287-296. 10.1002/immu.200310002 12548559
10. Monneaux F Dumortier H Steiner G Briand JP Muller S: Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB × NZW)F(1) lupus mice. Int Immunol 2001, 13:1155-1163. 10.1093/intimm/13.9.1155 11526096
11. Monneaux F Hoebeke J Sordet C Nonn C Briand JP Maillère B Sibillia J Muller S: Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analog. J Immunol 2005, 175:5839-5847. 16237076
12. Monneaux F Muller S: Key sequences involved in the spreading of the systemic autoimmune response to spliceosomal proteins. Scand J Immunol 2001, 54:45-54. 10.1046/j.1365-3083.2001.00942.x 11439147
13. Monneaux F Muller S: Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences. Arthritis Rheum 2002, 46:1430-1438. 10.1002/art.10263 12115171
14. Monneaux F Parietti V Briand JP Muller S: Intramolecular T cell spreading in unprimed MRL/lpr mice: Importance of the U1-70k protein sequence 131-151. Arthritis Rheum 2004, 50:3232-3238. 10.1002/art.20510 15476231
15. Barakat S Briand JP Weber JC van Regenmortel MH Muller S: Recognition of synthetic peptides of Sm-D autoantigen by lupus sera. Clin Exp Immunol 1990, 81:256-262. 1535060 2387092
16. Dumortier H Abbal M Fort M Briand JP Cantagrel A Muller S: MHC class II gene associations with autoantibodies to U1A and SmD1 proteins. Int Immunol 1999, 11:249-257. 10.1093/intimm/11.2.249 10069423
17. Neimark J Briand JP: Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavage capability. Pept Res 1993, 6:219-228. 8400618
18. Mutter M Nefzi A Sato T Sun X Wahl F Wöhr T: Pseudo-prolines (psi Pro) for accessing "inaccessible" peptides. Pept Res 1995, 8:145-153. 7670229
19. Muller S Plaué S Samama JP Valette M Briand JP Van Regenmortel MH: Antigenic properties and protective capacity of a cyclic peptide corresponding to site A of influenza virus haemagglutinin. Vaccine 1990, 8:308-314. 10.1016/0264-410X(90)90086-2 2396470
20. Beignon AS Briand JP Muller S Partidos CD: Immunization onto bare skin with synthetic peptides: Immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells. Immunology 2002, 105:204-212. 1782656 11872096 10.1046/ j.0019-2805.2001.01357.x
21. Furuichi K Ezoe H Obara T Oka T: Evidence for a naturally occurring anti-spermine antibody in normal rabbit serum. Proc Natl Acad Sci USA 1980, 77:2904-2908. 349514 6930674 10.1073/pnas.77.5.2904
22. Riemekasten G Weiss C Schneider S Thiel A Bruns A Schumann F Bläss S Burmester GR Hiepe F: T cell reactivity against the SmD1(83-119) C terminal peptide in patients with systemic lupus erythematosus. Ann Rheum Dis 2002, 61:779-785. 1754211 12176801 10.1136/ard.61.9.779
23. Riemekasten G Kawald A Weiss C Meine A Marell J Klein R Hocher B Meisel C Hausdorf G Manz R: Strong acceleration of murine lupus by injection of the SmD1(83-119) peptide. Arthritis Rheum 2001, 44:2435-45. 10.1002/ 1529-0131(200110)44:10<2435::AID-ART408>3.0.CO;2-0 11665986
24. Singh RR: Prevention and control of reciprocal T-B cell diversification: implications for lupus-like autoimmunity. Mol Immunol 2004, 40:1137-45. 10.1016/j.molimm.2003.11.029 15036920
25. Sercarz EE: Immune focusing vs diversification and their connection to immune regulation. Immunol Rev 1998. 164:5-10. 10.1111/ j.1600-065X.1998.tb01202.x 9795758
26. Deshmukh US Bagavant H Lewis J Gaskin F Fu SM: Epitope spreading within lupus-associated ribonucleoprotein antigens. Clin Immunol 2005, 117:112-120. 10.1016/j.clim.2005.07.002 16095971
27. Okubo M Kokubun M Nishimaki T Kasukawa R Ohto H Yamamoto K Muller S: T cell epitope mapping of U1-A RNP. Arthritis Rheum 1995, 38:1170-1172. 10.1002/art.1780380823 7639817
28. Suen JL Wu CH Chen YY Wu WM Chiang BL: Characterization of self-T-cell response and antigenic determinants of U1A protein with bone marrow-derived dendritic cells in NZB × NZW F1 mice. Immunology 2001, 103:301-309. 1783246 11454059 10.1046/j.1365-2567.2001.01255.x
29. Yang MH Suen JL Li SL Chiang BL: Identification of T-cell epitopes on U1A protein in MRL/lpr mice: Double-negative T cells are the major responsive cells. Immunology 2005, 115:279-286. 1782149 15885135 10.1111/ j.1365-2567.2005.02139.x
30. Hassan AB Gunnarsson I Karlsson G Klareskog L Forslid J Lundberg IE: Longitudinal study of interleukin-10, tumor necrosis factor-alpha, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease. Scand J Rheumatol 2001, 30:282-289. 10.1080/030097401753180363 11727843
31. McClain MT Lutz CS Kaufman KM Faig OZ Gross TF James JA: Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response. Proc Natl Acad Sci USA 2004, 101:3551-3556. 373500 14988508 10.1073/pnas.0306267101
32. James JA Gross T Scofield RH Harley JB: Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995, 181:453-461. 10.1084/jem.181.2.453 7530756
33. James JA Harley JB: A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice. J Immunol 1998, 160:502-508. 9552009
34. Mason LJ Timothy LM Isenberg DA Kalsi JK: Immunization with a peptide of Sm B/B' results in limited epitope spreading but not autoimmune disease. J Immunol 1999, 162:5099-5105. 10227979
35. Vlachoyiannopoulos PG Petrovas C Tzioufas AG Alexopoulos C Tsikaris V Guialis A Nakopoulou L Sakarellos-Daitsiotis M Sakarellos C Davaris P Moutsopoulos HM No evidence of epitope spreading after immunization with the major Sm epitope P-P-G-M-R-P-P anchored to sequential oligopeptide carriers (SOCs) J Autoimmun 2000 14 53 61 10.1006/jaut.1999.0344 10648116
36. Rai G Ray S Shaw RE Degrange PF Mage RG Newman BA: Models of systemic lupus erythematosus: Development of autoimmunity following peptide immunizations of noninbred pedigreed rabbits. J Immunol 2006, 176:660-667. 16365462
37. Kaliyaperumal A Michaels MA Datta SK: Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: Tolerance spreading impairs pathogenic function of autoimmune T and B cells. J Immunol 1999, 162:5775-5783. 10229810
38. Greidinger EL Foecking MF Schäfermeyer KR Bailey CW Primm SL Lee DR Hoffman RW: T cell immunity in connective tissue disease patients targets the RNA binding domain of the U1-70 kDa small nuclear ribonucleoprotein. J Immunol 2002, 169:3429-3437. 12218166